Literature DB >> 12794720

Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.

Isabella Abbate1, Mario Romano, Roberta Longo, Giuseppina Cappiello, Oreste Lo Iacono, Vito Di Marco, Concetta Paparella, Alberto Spano, Maria Rosaria Capobianchi.   

Abstract

To investigate the intra-hepatic activation of the IFN system in patients affected by chronic HCV-infection in comparison with that observed in a non-infectious liver disease such as non-alcoholic steatohepatitis, we measured the liver steady state mRNA levels of interferon-alpha, interferon-beta and interferon-gamma as well as of IFN-related genes (IFNAR-1, STAT1alpha, PKR, 2-5 AS, IRF-1, ICE and IL-18). In HCV-infected subjects, possible correlations of these parameters with viral load and liver injury were also analyzed. Twenty-four chronic untreated HCV-infected subjects and seven patients with non-alcoholic steatohepatitis were enrolled in the study. Liver biopsies were graded according to Knodell scores. Intra-hepatic mRNA levels of IFNs and related genes were assessed by semi-quantitative RT-PCR. In comparison with non-alcoholic steatohepatitis, in HCV-infected subjects IFN-alpha and -beta mRNA levels were significantly lower, whereas IFN-gamma, IFNAR-1, STAT1alpha IRF-1, and IL-18 mRNA were upregulated. Moreover, IFN-gamma mRNA steady state levels were correlated positively with those of IFNAR-1, IRF-1, and IL-18, suggesting a coordinated induction of these genes. Although plasma viral load was correlated inversely with IL-18-specific mRNA, viral load was not related to liver injury. IFN-gamma and IRF-1 mRNA levels were correlated positively with ALT, but not with the grading or staging. Conversely, IFN-alpha and -beta mRNA levels were higher in livers with lower staging scores. These findings support the hypothesis that in chronic HCV infection there is an imbalance between an upregulated IFN-gamma system and a downregulated IFN-alpha and -beta system, probably due to a mixed effect exerted by HCV-specific and inflammatory non-specific factors. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794720     DOI: 10.1002/jmv.10433

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Authors:  Esther Larrea; José I Riezu-Boj; Lucía Gil-Guerrero; Noelia Casares; Rafael Aldabe; Pablo Sarobe; María P Civeira; Jonathan L Heeney; Christine Rollier; Babs Verstrepen; Takaji Wakita; Francisco Borrás-Cuesta; Juan J Lasarte; Jesús Prieto
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.

Authors:  Adrien Breiman; Nathalie Grandvaux; Rongtuan Lin; Catherine Ottone; Shizuo Akira; Mitsutoshi Yoneyama; Takashi Fujita; John Hiscott; Eliane F Meurs
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass.

Authors:  M Bosch; A Lopez-Bermejo; J Vendrell; M Musri; W Ricart; J-M Fernandez-Real
Journal:  Diabetologia       Date:  2005-07-29       Impact factor: 10.122

4.  Antiviral and Immunoregulatory Effects of Indoleamine-2,3-Dioxygenase in Hepatitis C Virus Infection.

Authors:  Quentin Lepiller; Eric Soulier; Qisheng Li; Mélanie Lambotin; Jochen Barths; Dietmar Fuchs; Françoise Stoll-Keller; T Jake Liang; Heidi Barth
Journal:  J Innate Immun       Date:  2015-03-19       Impact factor: 7.349

5.  Regulation of hepatitis C virus replication by interferon regulatory factor 1.

Authors:  Nobuhiko Kanazawa; Masayuki Kurosaki; Naoya Sakamoto; Nobuyuki Enomoto; Yasuhiro Itsui; Tsuyoshi Yamashiro; Yoko Tanabe; Shinya Maekawa; Mina Nakagawa; Cheng-Hsin Chen; Sei Kakinuma; Shigeru Oshima; Tetsuya Nakamura; Takanobu Kato; Takaji Wakita; Mamoru Watanabe
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study.

Authors:  Jason Reingold; Christine Wanke; Donald Kotler; Cora Lewis; Russell Tracy; Steven Heymsfield; Phyllis Tien; Peter Bacchetti; Rebecca Scherzer; Carl Grunfeld; Michael Shlipak
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

7.  Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis.

Authors:  Arpita Sharma; Anuradha Chakraborti; Ashim Das; Radha Krishan Dhiman; Yogesh Chawla
Journal:  Immunology       Date:  2008-11-24       Impact factor: 7.397

8.  Interferon-α improves phosphoantigen-induced Vγ9Vδ2 T-cells interferon-γ production during chronic HCV infection.

Authors:  Eleonora Cimini; Cécile Bonnafous; Veronica Bordoni; Eleonora Lalle; Helene Sicard; Alessandra Sacchi; Giulia Berno; Cristiana Gioia; Gianpiero D'Offizi; Ubaldo Visco Comandini; Chrysoula Vlassi; Maria Rosaria Capobianchi; Federico Martini; Chiara Agrati
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

9.  IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.

Authors:  Licia Bordi; Claudia Caglioti; Anna Rosa Garbuglia; Daniele Lapa; Concetta Castilletti; Chiara Taibi; Maria Rosaria Capobianchi; Eleonora Lalle
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

10.  IFN-Alpha receptor-1 upregulation in PBMC from HCV naïve patients carrying cc genotype. possible role of IFN-lambda.

Authors:  Eleonora Lalle; Licia Bordi; Claudia Caglioti; Anna Rosa Garbuglia; Concetta Castilletti; Chiara Taibi; Francesca Cristofari; Maria Rosaria Capobianchi
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.